Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Medorion Announces Expansion Strategy For Its Member Behavior-Focused SaaS AI Platform

Bolstered Platform to Drive Member Behavior Health Insights for Health Plans’ Member Level Understanding, Risk Management and Care Management Utilization

Medorion, developer of Behavioral Intelligence SaaS solutions for health insurers, announced that it will broaden its AI-powered EBR (Electronic Behavioral Records) platform into additional health plan-related focus areas beyond Medorion’s current Behavioral Persuasion software, including a comprehensive member experience solution, risk adjustment and care management. These new implementations will utilize Medorion’s EBR™ platform to gain further insights into the “Why” factors that drive member health decisions.

Recommended AI News: Ceres Imaging Secures $23 Million in Series C Funding to Fuel Development of AI in Agriculture

Medorion’s market-proven platform leverages existing clinical and social determinants of health (SDoH) data to accurately pinpoint the underlying psychological and environmental barriers as well as the economic drivers behind people’s health decisions. Medorion’s technology relies on more than 50 years of behavioral science, AI/ ML expertise to create the SaaS-based EBR™ platform, the behavioral equivalent to an Electronic Health record (EHR).

“We are excited to announce the broader implementation of our behavioral insights platform into new avenues of member experience to bolster health plan offerings and capabilities,” said Asaf Kleinbort, co-founder and CEO of Medorion. “By leveraging our proven EBR™ platform, we can better understand why members behave the way they do and help health plans and healthcare organizations to elevate their understanding of members’ needs and truly personalize care while improving healthcare management delivery of services, and financial outcomes.”

Related Posts
1 of 30,057

Medorion’s expanded product offering includes:

  • Comprehensive Behavioral Persuasion software that automatically facilitates decision barrier based digital interactions to influence members’ health behavior.
  • A member-centric 360° SaaS that aggregates all behavioral records insights beyond the clinical setting, including behavioral member segmentation and characterization.
  • A behavioral actuary solution that leverages insights from members’ health decisions to improve risk management and insurance product planning.
  • A care management system that provides continuous insights into member behavior and service offering adjustment according to member’s individual needs.

Medorion’s EBR™ platform uses members’ health insights through automated preset digital tools that seamlessly enable omnichannel member accessibility, covering all member populations in multiple health measures, even those with minimal data associated with them. As a result, Medorion’s technology allows health plans to provide a unique member experience of personal relevance as opposed to a “personalized” one, allowing for improved member health and business outcomes.

The company recently released new data showing its software platform has brought double-digit enrollment, 1-star gains in several Part D measures, and increased retention rates to top health insurers across the U.S, over the last 18 months. Medorion also recently completed a $6 million funding round led by 10D, iAngels and TAU Ventures.

Recommended AI News: Introhive and BoardEx Announce Collaborative Partnership to Support Shared Clients

[To share your insights with us, please write to ]

Comments are closed.